Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

ZDHHC5 – Schizophrenia

Expression quantitative trait locus–based SMR analysis integrating GWAS data from 9,394 schizophrenia patients and 12,462 controls with eQTLs from 5,311 subjects implicates ZDHHC5 expression in schizophrenia (p = 7.45×10^-10)(PMID:29024729). This single-study association lacks supporting rare variant findings, segregation data, or family-based evidence. No pathogenic coding variants in ZDHHC5 have been described in schizophrenia cohorts, and no functional or mechanistic studies to date directly link ZDHHC5 perturbation to schizophrenia-relevant phenotypes. Under ClinGen guidelines, the gene–disease association is classified as Limited, indicating insufficient evidence for clinical diagnostic use or targeted therapy decisions.

References

  • Progress in neuro-psychopharmacology & biological psychiatry • 2018 • Integrating genome-wide association study and expression quantitative trait locus study identifies multiple genes and gene sets associated with schizophrenia. PMID:29024729

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Single integrative SMR study; no segregation or rare variant evidence

Genetic Evidence

Limited

Association based on summary-level expression data; lacks case-level variant data

Functional Evidence

Limited

No experimental studies linking ZDHHC5 function to schizophrenia phenotype